This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Renue Life Sciences Form D (2026)

Renue Life Sciences reported $250,000 raised in an SEC Form D filed on 2026-10-14.

Company
Renue Life Sciences
Round type
Form D
Date
2026-10-14
Amount
$250K
Industry
Biotechnology
Location
California

Summary

The SEC Form D for Renue Life Sciences, filed on 2026-10-14, reports $250,000 raised. It was listed in the Raise Track Update of 2026-10-15. Filing: https://www.sec.gov/Archives/edgar/data/2158207/000215820726000001/0002158207-26-000001-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/2158207/000215820726000001/0002158207-26-000001-index.htm
    Type: sec filing. Accessed 2026-10-15.
    SEC Form D for Renue Life Sciences, Inc. EDGAR filing date 2026-10-14. Signed 2026-10-13. First sale 2026-10-02. Total amount sold $250,000 of an offering amount of $3,000,000. 8 investors already invested. Issuer address city is San Carlos, California. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form gives a related person's name as Samuel David Perli. The page uses Samuel Perli.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
    Type: other verified public source. Accessed 2026-10-15.
    Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Renue Life Sciences, state CALIFORNIA, industry Biotechnology, amount raised $250,000.